"Rivastigmine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.
Descriptor ID |
D000068836
|
MeSH Number(s) |
D02.241.081.251.583.899
|
Concept/Terms |
Rivastigmine- Rivastigmine
- (S)-N-Ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate
RivastigmineTartrate- RivastigmineTartrate
- Rivastigmine Hydrogen Tartrate
- Hydrogen Tartrate, Rivastigmine
- Tartrate, Rivastigmine Hydrogen
ENA 713- ENA 713
- 713, ENA
- SDZ ENA 713
- 713, SDZ ENA
- ENA 713, SDZ
- ENA-713
- ENA713
|
Below are MeSH descriptors whose meaning is more general than "Rivastigmine".
Below are MeSH descriptors whose meaning is more specific than "Rivastigmine".
This graph shows the total number of publications written about "Rivastigmine" by people in this website by year, and whether "Rivastigmine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2014 | 0 | 1 | 1 |
2017 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2019 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Rivastigmine" by people in Profiles.
-
One-Year Persistence with Donepezil, Memantine, and Rivastigmine in More than 66,000 Elderly Patients Followed in Poland. J Alzheimers Dis. 2019; 70(3):899-905.
-
Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning. Curr Pharm Des. 2019; 25(33):3519-3535.
-
Gender Differences in Neuropsychiatric Symptoms in Mild to Moderate Alzheimer's Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A Post Hoc Analysis of the EVOLUTION Study. J Womens Health (Larchmt). 2018 11; 27(11):1368-1377.
-
Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study. PLoS One. 2017; 12(8):e0182547.
-
FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer's disease. Clin Interv Aging. 2014; 9:1783-91.